RXNICOTINE TECHNOLOGY LLC – Trademark Portfolio

Entity Type: 16

RXNICOTINE TECHNOLOGY LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include RX TECH, RXNICOTINE, and SENSORY STICK. The owner is based in Pompano Beach, FL.

3951 NE 19th Rd #1703

Pompano Beach, FL 33064

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

RXNICOTINE TECHNOLOGY LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (4 filings)

Tobacco; smokers articles; matches

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does RXNICOTINE TECHNOLOGY LLC have?

RXNICOTINE TECHNOLOGY LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.

What trademark classes does RXNICOTINE TECHNOLOGY LLC file in?

RXNICOTINE TECHNOLOGY LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 5 (Pharmaceuticals). Class 34 covers tobacco; smokers articles; matches.

What are RXNICOTINE TECHNOLOGY LLC's most well-known trademarks?

RXNICOTINE TECHNOLOGY LLC's registered trademark portfolio includes well-known marks such as RX TECH, RXNICOTINE, and SENSORY STICK. These are among 3 currently registered trademarks in the portfolio.

What is RXNICOTINE TECHNOLOGY LLC's trademark registration success rate?

RXNICOTINE TECHNOLOGY LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.